Literature DB >> 6098853

Muscarinic activation of rhombencephalic neurones controlling oesophageal peristalsis in the rat.

D Bieger.   

Abstract

The role of muscarinic cholinergic mechanisms in the brainstem in the control of oesophageal peristalsis was investigated in rats anaesthetized with urethane. Primary deglutitive peristalsis, evoked by electrical stimulation of the brainstem or intravenous administration of the serotonin agonist quipazine, was abolished for periods of 1.5 to 2 h by scopolamine and atropine (0.1-0.2 microM/kg) as well as by methscopolamine (1.25-5 microM/kg). In contrast, the buccopharyngeal stage of evoked swallowing was facilitated. A deglutitive effector area was mapped in the intermediolateral portion of the solitary complex by the use of micropneumophoretic application of S-glutamate (35-350 pM) and the cholinoceptor agonists D,L-muscarine and acetylcholine (50-100 pM). Scopolamine partially antagonized single propulsive contractions of the oesophagus evoked by S-glutamate, but completely inhibited rhythmic propulsive or synchronous oesophageal contractions evoked by muscarinic agonists or acetylcholine. Injection of S-glutamate or acetylcholine into the ambiguus complex produced propulsive or non-propulsive oesophageal responses depending on location. Responses evoked by acetylcholine were potentiated by systemic administration of physostigmine, but were resistant to scopolamine; propulsive responses evoked by S-glutamate were partially inhibited by scopolamine. Injection of the retrogradely-transported fluorescent tracer bisbenzimide into the rostral ambiguus complex resulted in labelling of a discrete cell group located within the deglutitive region of the solitary complex. It is concluded that this region contains premotor elements forming part of the internuncial network organizing oesophageal peristalsis. The source of postulated cholinergic afferents to these neurones remains to be identified.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098853     DOI: 10.1016/0028-3908(84)90088-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism.

Authors:  J C Fang; I Sarosiek; Y Yamamoto; J Liu; R K Mittal
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 2.  Neuropharmacologic correlates of deglutition: lessons from fictive swallowing.

Authors:  D Bieger
Journal:  Dysphagia       Date:  1991       Impact factor: 3.438

Review 3.  Brain stem control of the phases of swallowing.

Authors:  Ivan M Lang
Journal:  Dysphagia       Date:  2009-04-28       Impact factor: 3.438

4.  Atropine inhibits gastric distension and pharyngeal receptor mediated lower oesophageal sphincter relaxation.

Authors:  R K Mittal; C Chiareli; J Liu; R H Holloway; W Dixon
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Nicotinic cholinoceptor-mediated excitatory postsynaptic potentials in rat nucleus ambiguus.

Authors:  M Zhang; Y T Wang; D M Vyas; R S Neuman; D Bieger
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 6.  The brainstem esophagomotor network pattern generator: a rodent model.

Authors:  D Bieger
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 7.  Central neural control of esophageal motility: a review.

Authors:  E T Cunningham; P E Sawchenko
Journal:  Dysphagia       Date:  1990       Impact factor: 3.438

Review 8.  Suitability of urethane anesthesia for physiopharmacological investigations. Part 3: Other systems and conclusions.

Authors:  C A Maggi; A Meli
Journal:  Experientia       Date:  1986-05-15

Review 9.  In search of a longitudinal animal model of evoked swallow function.

Authors:  Jared Langerman; Sotirios G Doukas; Hisashi Hasegawa; James Goodrich; Michael Lerner; Clarence Sasaki
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.